GlassScriptPhysician profile
Sarah Beth Brown
NPI 1356840433
$318.59
in general payments reported to CMS, 2019-2025
10 companies · $98.78 in 2025
The $98.78 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $41.86 · 2022: $53.87 · 2024: $124 · 2025: $98.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $223.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $222.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $76.11 | 2025 | Jornay Pm |
| Exact Sciences Corporation | $41.64 | 2024 | Cologuard Collection Kit |
| E.R. Squibb & Sons, L.L.C. | $34.29 | 2024 | Camzyos |
| Lilly USA, LLC | $33.20 | 2024 | Zepbound, Mounjaro |
| Medtronic, INC. | $28.61 | 2022 | |
| Genentech USA, INC. | $28.49 | 2021 | |
| Glaxosmithkline, LLC. | $25.26 | 2022 | |
| Lundbeck LLC | $22.67 | 2025 | Vyepti |
| Ferring Pharmaceuticals INC. | $14.95 | 2024 | Rebyota |
| Gilead Sciences, INC. | $13.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.